caratherapeutics.com (CARA) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Biotexnologiya biznesi noyob reagentlar yetkazib berishdagi uzilishlar va xalqaro patent himoyasiga oid murakkabliklar tufayli zaifdir. Ushbu narxlar grafigi aktivning dinamikasini aks ettiradi, bunda joriy ko'rsatkich 0.00 ni tashkil etadi. Cara Therapeutics, Inc. (CARA) o'z laboratoriyalarida energiya tejamkor texnologiyalar va emissiyalarni filtrlash tizimlarini joriy qilmoqda. Biroq, renal qichishishni davolash vositalarini ishlab chiqish muvaffaqiyatsiz sinovlar va asosiy hamkorlarning ketishi sababli to'xtab qolmoqda.
&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_CARA_-_Cara-Therapeutics-Inc._-_Long-Term-Debt-to-Equity-Ratio "CARA - Cara Therapeutics Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 01.11.2026 oraligʻida | 👁️GURU.Markets👁️")
Cara Therapeutics, Inc. (CARA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Cara Therapeutics, Inc.|CARA - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati caratherapeutics.com|CARA - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Cara Therapeutics, Inc.|CARA - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli kredit va qarzlari Cara Therapeutics|Tezkor likvidlik koeffitsiyenti caratherapeutics.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning jamlanma tahlili:CARA, Cara Therapeutics Inc.
Muvaffaqiyatsiz sinovlardan so'ng o'z loyihalari portfelini qayta shakllantirayotgan Cara Therapeutics, Inc. (CARA) uchun uzoq muddatli qarzdorlik biznesning xavfsizlik zaxirasini belgilaydi. Ushbu ko'rsatkich bir yildan ortiq muddatga ega majburiyatlarni kapital bilan solishtiradi. Joriy uzoq muddatli qarzning kapitalga nisbatini tahlil qilish orqali investorlar kompaniyaning tashqi qarzga bog'liqligini baholaydilar. Kundalik hisob-kitoblar hisobotlardagi choraklik bo'shliqlarni bartaraf etadi va ularga haqiqiy likvidlikni bozor kutganlari bilan farqlash imkonini beradi.
Raqobatdosh kompaniyalar tahlili
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|DNLI (Denali Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati harmonybiosciences.com (HRMY)|Uzoq muddatli qarzning kapitalga nisbati BHVN|Uzoq muddatli qarzning kapitalga nisbati Amylyx Pharmaceuticals Inc (AMLX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevi Pharma TRVI|Uzoq muddatli qarzning kapitalga koeffitsiyenti PRAX|Anavex Life Sciences - Uzoq muddatli qarzning kapitalga nisbati|CBLL - Uzoq muddatli qarzning kapitalga nisbati|PRTA (Prothena Corp) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Alector - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati ANNX|OMER (Omeros Corp.) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati NGNE|ACIU (acimmune.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati VYGR (Voyager Therapeutics, Inc.)|Neumora (NMRA) - Uzoq muddatli majburiyatlarning kapitalga nisbati|SCLX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TVGN (Tevogen Bio Inc.)|ACOG: Uzoq muddatli qarzning kapitalga nisbati|cogrx.com (CGTX) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Inhibikase Therapeutics, Inc.|Cassava Sciences Inc - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ASRT|COYA - Uzoq muddatli majburiyatlarning kapitalga nisbati|Vistagen - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Ovid Therapeutics Inc OVID|ABOS: Uzoq muddatli qarzning o'z kapitaliga nisbati|CervoMed, Inc. - Uzoq muddatli kreditlarning kapitalga nisbati|ATHE: Uzoq muddatli qarzning kapitalga nisbati|CLNN - Uzoq muddatli qarzdorlikning kapitalga nisbati|PEPG (PepGen Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati jupiterneurosciences.com (JUNS)|Uzoq muddatli qarzning o'z kapitaliga nisbati Relmada Therapeutics, Inc. (RLMD)|Uzoq muddatli qarzdorlikning kapitalga nisbati Annovis Bio Inc|Grace Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti AIFF|ANEW Medical, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati NeuroSense Therapeutics NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi MTVA|NRXS (NeurAxis, Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Helius Medical Technologies Inc. (HSDT)|Uzoq muddatli qarzning o'z kapitaliga nisbati PASG (Passage Bio, Inc.)|Uzoq muddatli qarzdorlikning kapitalga nisbati bionomics.com.au|Uzoq muddatli qarzning kapitalga nisbati NERV (Minerva Neurosciences, Inc.)|ATHA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Addex Therapeutics, Ltd. - Uzoq muddatli qarzning kapitalga nisbati|ALZN - Uzoq muddatli qarzning kapitalga nisbati|cyclerion.com (CYCN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Protagenic Therapeutics, Inc. - Uzoq muddatli qarzning kapitalga koeffitsiyenti|KTTA (Pasithea Therapeutics Corp) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Cortigent Medical|Uzoq muddatli qarzning o'z kapitaliga nisbati Avenue Therapeutics, Inc (ATXI)|BrainStorm Cell Therapeutics Inc. - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati CHRO (Chromocell Therapeutics)|Eliem Therapeutics, Inc. (ELYM) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ITCI: Uzoq muddatli qarzning o'z kapitaliga nisbati|LBPH - Uzoq muddatli qarzning kapitalga nisbati|Marinus (MRNS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NKGen Biotech Corp - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati NeuroBo Pharmaceuticals|Uzoq muddatli majburiyatlarning kapitalga nisbati sagerx.com SAGE|Uzoq muddatli qarzning kapitalga nisbati SNPX|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevena Inc. TRVN|Uzoq muddatli qarzning kapitalga nisbati VIGL (Vigil Neuroscience, Inc.)|Uzoq muddatli qarzning kapitalga nisbati Anew Medical Inc. WENA|CERE - Uzoq muddatli qarzning o'z kapitaliga nisbati